Associate Professor, Urology and Epidemiology and Biostatistics; Helen Diller Family Chair in Urology. UCSF Comprehensive Cancer Center
Urology
Dr. Matthew R. Cooperberg, MD
|
|
Give Review
Matthew Cooperberg is an expert in the field of Urology. He researched medicine at Yale University School of Medicine. Yale University School of Medicine is a top medical college. Yale University School of Medicine is ranked 7/57 in Research/PrimaryCare. He has 2 awards "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACS)". Doctor Matthew R. Cooperberg, MD is a published doctor. He published 93 publications, including: 'Application of a Clinical Whole-Transcriptome Assay for Staging and Prognosis of Prostate Cancer Diagnosed in Needle Core Biopsy Specimens.' He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Application of a Clinical Whole-Transcriptome Assay for Staging and Prognosis of Prostate Cancer Diagnosed in Needle Core Biopsy Specimens.
- Outcomes of Active Surveillance for Clinically Localized Prostate Cancer in the Prospective, Multi-Institutional Canary PASS Cohort.
- Re: Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma.
- The Comparative Harms of Open and Robotic Prostatectomy in Population Based Samples.
- Treatment Trends for Prostate Cancer--Reply.
- Is computed tomography a necessary part of a metastatic evaluation for castration-resistant prostate Cancer? Results from the Shared Equal Access Regional Cancer Hospi...
- Immediate versus deferred initiation of androgen deprivation therapy in prostate Cancer patients with PSA-only relapse. An observational follow-up study.
- Nationally representative trends and geographic variation in treatment of localized prostate Cancer: the Urologic Diseases in America project.
- Impact of Age on Quality-of-life Outcomes After Treatment for Localized Prostate Cancer.
- Prostate-specific antigen level, stage or Gleason score: Which is best for predicting outcomes after radical Prostatectomy, and does it vary by the outcome being measu...
- Post-operative Radiation Therapy for Patients at High-risk of Recurrence after Radical Prostatectomy: Does Timing Matter?
- Diagnostic associations of gene expression signatures in prostate Cancer tissue.
- The Current Utilization of Imaging After Primary Treatment for Prostate Cancer.
- Reply to Yuri Tolkach, Markus Kuczyk, Florian Imkamp's Letter to the Editor re: Eric A. Klein, Matthew R. Cooperberg, Cristina Magi-Galluzzi, et al. A 17-gene Assay to...
- Is clinical stage T2c prostate Cancer an intermediate- or high-risk disease?
- Postoperative statin use and risk of biochemical recurrence following radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) dat...
- Expected population impacts of discontinued Prostate-specific antigen screening.
- Overdetection of recurrence after radical Prostatectomy: estimates based on patient and tumor characteristics.
- Serum Lipid Profile and Risk of Prostate Cancer Recurrence: Results from the SEARCH Database.
- Progress in Management of Low-risk Prostate Cancer: How Registries May Change the World.
- Long-term Health-related Quality of Life After Primary Treatment for Localized Prostate Cancer: Results from the CaPSURE Registry.
- Extended Follow-Up and Risk Factors for Disease Reclassification from a Large Active Surveillance Cohort for Localized Prostate Cancer.
- Trans-Pacific Variation in Outcomes for Men Treated With Primary Androgen Deprivation Therapy for Prostate Cancer.
- The Evolution of Self-Reported Urinary and Sexual Dysfunction over the Last Two Decades: Implications for Comparative Effectiveness Research.
- European Urology: Serving Our Readership Through Systematic Peer Review, Use of Reporting Standards, and Encouragement of Postpublication Review.
- Implications of the new AUA guidelines on prostate Cancer detection in the U.S.
- A 17-gene Assay to Predict Prostate Cancer Aggressiveness in the Context of Gleason Grade Heterogeneity, Tumor Multifocality, and Biopsy Undersampling.
- Early detection of prostate Cancer.
- Updated trends in imaging use in men diagnosed with prostate Cancer.
- Prostate Cancer: A new look at prostate Cancer treatment complications.
- Racial Variation in Prostate Cancer Upgrading and Upstaging Among Men with Low-risk Clinical Characteristics.
- Predicting bone scan positivity after biochemical recurrence following radical Prostatectomy in both hormone-naive men and patients receiving androgen-deprivation ther...
- A risk-adjusted definition of biochemical recurrence after radical Prostatectomy.
- Impact of national guidelines on brachytherapy monotherapy practice patterns for prostate Cancer.
- Meaningful end points and outcomes in men on active surveillance for early-stage prostate Cancer.
- The impact of pathologic staging on the long-term oncologic outcomes of patients with clinically high-risk prostate Cancer.
- Temporal trends and predictors of salvage Cancer treatment after failure following radical prostatectomy or radiation therapy: An analysis from the CaPSURE registry.
- Contemporary prevalence of pretreatment urinary, sexual, hormonal, and bowel dysfunction: Defining the population at risk for harms of prostate Cancer treatment.
- Metformin does not affect risk of biochemical recurrence following radical Prostatectomy: results from the SEARCH database.
- Management of biochemical recurrence after primary treatment of prostate Cancer: a systematic review of the literature.
- Limited ability of existing nomograms to predict outcomes in men undergoing active surveillance for prostate Cancer.
- Use of Social Media in Urology: Data from the American Urological Association.
- Long-term follow-up of International Prostate Symptom Score (IPSS) in men following Prostate brachytherapy.
- Cigarette smoking is associated with an increased risk of biochemical disease recurrence, metastasis, castration-resistant prostate Cancer, and mortality after radical...
- Impact of Androgen Deprivation Therapy on Mental and Emotional Well-Being in Men with Prostate Cancer: Analysis from the CaPSURE (Cancer of the Prostate Strategic Urol...
- Re-examining racial disparities in prostate Cancer outcomes.
- A longitudinal study of anxiety, depression and distress as predictors of sexual and urinary quality of life in men with prostate Cancer.
- Using a population-based observational cohort study to address difficult comparative effectiveness research questions: the CEASAR study.
- Divorcing diagnosis from treatment: contemporary management of low-risk prostate Cancer.
- Reply from Authors re: Ronald C. Chen. Making Individualized Decisions in the Midst of Uncertainties: The Case of Prostate Cancer and Biochemical Recurrence. Eur Urol....
- Re: Quality-of-life Effects of Prostate-specific Antigen Screening.
- Patient Demographics, Quality of Life, and Disease Features of Men With Newly Diagnosed Prostate Cancer: Trends in the PSA Era.
- The epidemiology of high-risk prostate Cancer.
- Multi-institutional Validation of the CAPRA-S Score to Predict Disease Recurrence and Mortality After Radical Prostatectomy.
- Validation of a Cell-Cycle Progression Gene Panel to Improve Risk Stratification in a Contemporary Prostatectomy Cohort.
- How does robot-assisted radical prostatectomy (RARP) compare with open surgery in men with high-risk prostate Cancer?
- Proximal bulbar periUrethral abscess.
- Role of active surveillance in the management of localized prostate Cancer.
- Reply to Jai Prakash, Apul Goel and Manish Garg's Letter to the Editor re: Anobel Y. Odisho, Anna B. Berry, Ardalan E. Ahmad, Matthew R. Cooperberg, Peter R. Carroll, ...
- High-risk nonmuscle invasive Bladder cancer: definition and epidemiology.
- Early Detection of Prostate Cancer: More Information, More Clarity.
- Will Biomarkers Save Prostate Cancer Screening?
- Active Surveillance for Prostate Cancer: A Systematic Review of the Literature.
- The quantitative Gleason score improves prostate Cancer risk assessment.
- Urological Cancer: For localized prostate Cancer, does technology equal progress?
- PSA screening: determinants of primary-care physician practice patterns.
- To Predict the Future, Consider the Present as Well as the Past.
- Reflex ImmunoCyt Testing for the Diagnosis of Bladder Cancer in Patients with Atypical Urine Cytology.
- Thwarting High-risk Prostate Cancer: The Right Treatments for the Right Patients.
- Fifth Joint Meeting of J-CaP and CaPSURE: Advancing the Global Understanding of Prostate Cancer and Its Management.
- Outcomes for radical Prostatectomy: is it the singer, the song, or both?
- Adverse Effects of Androgen Deprivation and the Limits of National Tumor Registries.
- High-risk prostate Cancer: treat the prostate.
- External-beam radiation therapy should be given with androgen deprivation treatment for intermediate-risk prostate Cancer: new confirmatory evidence.
- Among potent men post radical Prostatectomy, does the need for phosphodiesterase inhibitors have an impact on sexual bother scores?
- Prediction of erectile function following treatment for prostate Cancer.
- Androgen Deprivation Therapy and Cardiovascular Risk.
- Active Surveillance for Prostate Cancer: Progress and Promise.
- Treatment trends for stage I Renal cell carcinoma.
- The CAPRA-S score: A Straightforward Tool for Improved Prediction of Outcomes After Radical Prostatectomy.
- Changes in Prostate Cancer Grade on Serial Biopsy in Men Undergoing Active Surveillance.
- The relationship between prostate specific antigen change and biopsy progression in patients on active surveillance for prostate Cancer.
- Factors associated with downgrading in patients with high grade prostate Cancer.
- Impact of androgen deprivation on physical well-being in patients with prostate Cancer: analysis from the CaPSURE (Cancer of the Prostate Strategic Urologic Research E...
- The example of CaPSURE: lessons learned from a national Disease registry.
- Reply to comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate Cancer.
- Serum prostate-specific antigen for the early detection of prostate Cancer: always, never, or only sometimes?
- Inaccuracies in assignment of clinical stage for localized prostate Cancer.
- Impact of age at diagnosis on prostate Cancer treatment and survival.
- Outcomes of active surveillance for men with intermediate-risk prostate Cancer.
- Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate Cancer.
- Disproportionate presentation of high risk prostate Cancer in a safety net health system.
Schools
Yale University School Of Medicine
YaleNew Haven Hospital
Ucsf Medical Center
Procedures Preformed
- Complete Nephrectomy With Robotic Assistance
- Cystourethroscopy and TransUrethral Resection of Bladder Neck
- Kidney and Ureter Removal
- Kidney Stone Removal (Percutaneous Nephrostolithotomy, PCNL)
- View All
Conditions Treated
- Bladder Cancer
- Bladder Infection
- Bladder Stones
- Blood in Urine (Hematuria)
- View All
Doctors Specialties
- Urology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACS)
Education
-
UCSF -
Yale-New Haven Hospital -
Yale University School of Medicine
Hospital
-
UCSF Medical Center -
San Francisco VA Medical Center -
San Francisco General Hospital and Trauma Center
Drug Facts
| NPI NUMBER | 1841219326 | |
| NPPES Provider LastName | COOPERBERG | |
| NPPES Provider FirstName | MATTHEW | |
| NPPES Provider ZIPCode | 941431711 | |
| NPPES Provider State | CA | |
| Specialty Description | Urology | |
| Total Claim Count | 203.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1841219326 |
| Last Name Of The Provider | COOPERBERG |
| First Name Of The Provider | MATTHEW |
| View All |
Similar Doctors
|
|
Dr. Michael H. Humphreys, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Maxwell V. Meng, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Kirsten L. Greene, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jack W. McAninch, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jerome M. Weiss, MD |
|
|
Dr. Peter R. Carroll, MD |
|
|
Dr. Katsuto Shinohara, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas Chi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Catherine R. Harris, MD |
|
|
Dr. Wenwu Jin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Herbert J. Konkoff, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Jan Breza |